We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you ...

Emergent BioSolutions (NYSE:EBS) stock is trading higher on Thursday after the company announced the sale of its facility in Baltimore-Camden to Bora Pharmaceuticals. What Happened: On Thursday prior ...

Emergent BioSolutions, Inc. (NYSE:EBS) shares surged higher Thursday after the company announced operational changes to stabilize its financial position and reported first-quarter financial results.

Gaithersburg, Maryland-based Emergent BioSolutions has received Food and Drug Administration approval for use of its existing smallpox vaccine as a vaccine for the mpox virus. The vaccine, known as ...

An analyst initiated coverage of Emergent BioSolutions (NYSE: EBS) stock as the last trading week of 2024 kicked off, and investors reacted quite positively to the move. On the news, they piled into ...

Emergent BioSolutions' top line has been nosediving in recent quarters. The company's operations are also unprofitable, and the business is burning through cash. Its flagship product, Narcan, will ...

Emergent BioSolutions (NYSE:EBS) layoffs are in the news as the life sciences company prepares to cut jobs and close down certain facilities. According to a release from Emergent BioSolutions, these ...

Emergent BioSolutions Inc. will hold a conference call on August 6, 2025, at 5:00 PM Eastern Time to discuss its financial results for the second quarter of 2025. Participants can join the call via a ...

How does the mpox outbreak impact Emergent BioSolutions? The only approved vaccine for preventing mpox is made by Bavarian Nordic. However, the U.S. Centers for Disease Control and Prevention (CDC) ...

View Emergent BioSolutions Inc. EBS stock quote prices, financial information, real-time forecasts, and company news from CNN.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Emergent had positioned itself ...

Two top executives at Emergent BioSolutions are testifying before a House subcommittee May 19 as part of an investigation into the company’s COVID-19 contracts and manufacturing processes. At the ...